Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Creative Commons License

Balli M., Tasolar H., Cetin M., Hatem E., ÇAĞLIYAN Ç. E., Seker T., ...Daha Fazla

JOURNAL OF CARDIOLOGY, cilt.67, ss.327-330, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.jjcc.2015.09.018
  • Dergi Adı: JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.327-330
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: Contrast-induced nephropathy (CIN) is an iatrogenic problem in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Atrial fibrillation (AF) may also contribute to impaired kidney function. Several factors may contribute to the development of CIN. In patients with STEMI, concomitant AF is associated with higher in-hospital/follow-up mortality and morbidity. Therefore, we aimed to investigate the relationship between AF and CIN developments.